Another aspect of the galactosemia enigma

Molecular Genetics and Metabolism

Volumn 81, Issue 3, 2004, Pages 253-254

  Segal, Stanton ^a   Schadewaldt, Peter ^b   Lilburn, Margaret ^c   Wendel, Udo ^b   Lee, Philip ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTITOL; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; SUGAR;

ADULT; ANAMNESIS; CARBOHYDRATE DIET; CASE REPORT; CLINICAL FEATURE; DETERIORATION; ENZYME DEFICIENCY; FEMALE; GALACTOSEMIA; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HOMOZYGOSITY; HUMAN; LABORATORY TEST; LACTOSE TOLERANCE; LETTER; PRIORITY JOURNAL;

EID: 1242292942     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.12.002     Document Type: Letter

References (22)

1. S. Segal Galactosemia today: the enigma and the challenge J. Inherit. Metab. Dis. 21 1998 445 471
2. D.D. Wagganer N.R.M. Biest G. Donnell Long term prognosis in galactosemia: results of a survey of 350 cases J. Inherit. Metab. Dis. 13 1990 802 818
3. P.J. Lee M. Lilburn V. Wendel P. Schaderwalt A woman with untreated galactosemia Lancet 362 2003 446 447
4. S. Segal G.T. Berry Disorders of galactose metabolism C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Diseases seventh ed 1995 McGraw-Hill New York 967 1000
5. G.T. Berry R.H. Singh A.T. Mazur N. Guerrero M.J. Kennedy J. Chen R. Reynolds M.J. Palmieri P.D. Klein S. Segal L.J. Elias II Galactose breath testing distinguishes variant and severe galactose-1-phosphate uridyltransferase genotypes Pediatr. Res. 48 2000 323 328
6. 14C galactose by patients with congenital galactosemia: evidence for a direct oxidative pathway Am. J. Med. 44 1968 340 347
7. L.S. Wehrli G.T. Berry M. Palmieri A. Mazur L. Elias III S. Segal Urinary galactonate in patients with galactosemia: Quantitation by nuclear magnetic resonance spectroscopy Pediatr. Res. 42 1997 858 861
8. R.L. Turnquist T.A. Gillett R.G. Hensen Uridine diphosphate glucose pyrophosphorylase crystallization and properties of the enzyme from rabbit liver and species comparison J. Biol. Chem. 249 1974 7695 7700
9. 13C galactose by lymphoblasts from patients with galactosemia determined by NMR spectroscopy Mol. Genet. Metab. 77 2002 296 303
10. M. Palmieri A. Mazur G.T. Berry C. Ning S. Wehrli C. Yager R. Reynolds R. Singh R. Muralidharan S. Langley L. Elsas S. Segal Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia Metabolism 48 1999 1294 1302
11. C. Ning R. Reynolds J. Chen C. Yager G.T. Berry N. Leslie S. Segal Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week old animals fed a high-galactose diet Mol. Genet. Metab. 73 2001 306 315
12. R. Quan-Ma H.J. Wells W.W. Wells Galactitol in the tissues of a galactosemic child Am. J. Dis. Child 112 1966 477 478
13. Z.J. Wang G.T. Berry S.F. Dreka H. Zhao S. Segal R.A. Zimmerman Proton magnetic resonance spectroscopy of brain metabolites in galactosemia Ann. Neurol. 50 2001 266 269
14. C. Yager C. Ning R. Reynolds S. Segal Galactitol and galactonate accumulation in heart and skeletal muscle of mice with deficiency of galactose-1-phosphate uridyltransferase Mol. Genet. Metab. 81 2004 105 111
15. Y. Ai Z. Zheng A. O’Brien-Jenkins D.J. Bernard T. Wynshaw-Boris C. Ning R. Reynolds S. Segal K. Huang D. Stambolian A mouse model of galactose-induced cataracts Hum. Mol. Genet. 9 2000 1821 1827
16. A.Y. Lee S.K. Chunag S.S. Chuang Demonstration that polyol accumulation is responsible for diabetic cataract by use of transgenic mice expressing aldose reductase in the lens Proc. Natl. Acad. Sci. USA 92 1995 2780 2784
17. C.R. Scriver P.J. Waters Monogenic traits are not simple: lessons from phenylketonuria Trends Genet. 15 1999 267 272
18. K.M. Dipple E.R.B. McCabe Phenotypes of patients with “simple” Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics Am. J. Hum. Genet. 66 2000 1729 1735
19. K.M. Dipple E.R.B. McCabe Modifier genes convert “simple” Mendelian disorders to complex traits Mol. Genet. Metab. 71 2000 43 50
20. K.M. Dipple J.K. Phelan E.R.B. McCabe Consequences of complexity within biological networks: robustness and health, or vulnerability and disease Mol. Genet. Metab. 74 2001 45 50
21. H. Jeong B. Tombor R. Albert Z.N. Ottval A.-L. Barabasi The large-scale organization of metabolic networks Nature 407 2000 651 654
22. D. Elsenberg E.M. Marcotte I. Xenarios T.O. Yeates Protein function in the post-genomic era Nature 405 2000 823 826